title: [Splicing variant of androgen receptors (AR-V7): New paradigms].
authors: Centre Oscar-Lambret, Department of Medical Oncology, 3, rue Frédéric-Combemale, 59020, Lille, France. Electronic address: n-penel@o-lambret.fr.
authors: Nicolas
authors: N
authors: Penel
mesh_terms: D017398:Alternative Splicing; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000736:Androstenes / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001549:Benzamides; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D014644:Genetic Variation; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D011944:Receptors, Androgen / Q000235:genetics* / Q000378:metabolism; D043823:Taxoids / Q000627:therapeutic use
chemical_list: C410798:AR protein, human; D000726:Androgen Antagonists; D000736:Androstenes; D018931:Antineoplastic Agents, Hormonal; D001549:Benzamides; D014408:Biomarkers, Tumor; D009570:Nitriles; D011944:Receptors, Androgen; D043823:Taxoids; D010669:Phenylthiohydantoin; C540278:enzalutamide; D017430:Prostate-Specific Antigen; C089740:abiraterone